Pharmacovigilance study of the association between dipeptidyl peptidase-4 inhibitors and angioedema using the fda adverse event reporting system (faers)

HIGHLIGHTS

• who: Katsuhiro Ohyama from the Center for ExperientialTokyo University have published the research work: Pharmacovigilance study of the association between dipeptidyl peptidase-4 inhibitors and angioedema using the FDA Adverse Event Reporting System (FAERS), in the Journal: Scientific Reports Scientific Reports
• what: This study evaluated the association between DPP-4Is and angioedema, including cases with and without the concomitant use of ACEIs.

SUMMARY

Between DPP-4Is and angioedema by the reporting odds ratio (ROR) value, which is a non-Bayesian frequentist ­method20, and information component (IC) values, which is a Bayesian . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.